2025 Columbia Cornell Obesity: Etiology, Prevention, and Treatment On Demand

Obesity: Etiology, Prevention, and Treatment

Format: Video-recorded lectures
Access: Participants who complete the course by the stated expiration date will have continued access to course materials for three years after that date. 

Target Audience

This activity is designed for all health professionals, including physicians, dentists, nurse practitioners, physician assistants, and others.

For physicians interested in obtaining obesity medicine certification through the American Board of Obesity Medicine (ABOM), this course counts towards the ABOM requirement of at least 30 hours of ABOM-designated GROUP 1 credits.

This course is available in a two-course package, which provides learners with over 60 credits, fulfilling the credit requirement to apply for the ABOM exam. 

Course Overview

Obesity: Etiology, Prevention, and Treatment offers a comprehensive overview of obesity medicine, providing you with the knowledge and tools to manage obesity effectively. This course focuses on complex case management, integrates pharmacological and surgical options with lifestyle modifications, and covers childhood, adolescent, and adult populations.

Agenda

Click here to view the complete agenda.
 

Educational Objectives

Upon completion of this activity, learners should be able to:

  1. Discuss the complexity of the development and treatment of obesity.
  2. Identify, classify, and determine appropriate treatment approaches for people with obesity, including lifestyle, advanced pharmacological approaches, and metabolic surgery.
  3. Implement strategies that target childhood, adolescent, and adult populations to promote better health across the lifespan.
  4. Evaluate patients' unique circumstances through detailed case management.

Accreditation Statement

The Columbia University Vagelos College of Physicians and Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Columbia University Vagelos College of Physicians and Surgeons designates this enduring material for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 30.0 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Course Pricing

Physicians: $850.00

  • Discounted rates are available for non-physician healthcare professionals, fellows, residents, students, Columbia/Cornell/NYP personnel, military personnel, academic affiliates, groups of five or more, and past Columbia Cornell course participants. Please inquire with the Institute of Human Nutrition at ihnce@cumc.columbia.edu for discount pricing codes. 
Course Packages: Available during checkout

If you purchase the course as part of a package, content for the first course will automatically open after your purchase. You may close the content and return to the course when ready. To view all courses, please click on the My Account tab. Use the Login Page to log in and review any course by navigating to the My Account tab. 

Faculty and Disclosures

All those involved with the planning and delivery of this education will disclose all financial relationships in the past 24 months with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For each financial relationship, disclosure will include the name of the ineligible company and the nature of the financial relationship(s).

  • Louis Aronne, MD, FACP, FTOS, DABOM: Altimmune Consultant/Advisory Board, Research Funding; Amgen Consultant/Advisory Board; Boehringer-Ingelheim Consultant/Advisory Board; Currax Pharmaceuticals Consultant, Advisory Board; Eli Lilly Consultant/Advisory Board, Research Funding; ERX Pharmaceuticals Board of Directors; Jamieson Wellness Consultant/Advisory Board, Board of Directors, Equity Interest; Janssen Pharmaceuticals Consultant/Advisory Board; Jazz Pharmaceuticals Consultant/Advisory Board; Calliope Equity Interests; MBX Bioscience Equity Interests; Mediflix Equity Interests; Novo Nordisk Consultant/Advisory Board, Research Funding; Pfizer Consultant/Advisory Board; Skye Bioscience Research Funding, Equity Interests; Syntis Bio Equity Interest; Very Pharmaceuticals Consultant/Advisory Board, Equity Interest; Zealand Pharmaceuticals Consultant/Advisory Board
  • Ariana Chao, PhD, CRNP, FNP-BCRN: Boehringer Ingelhiem Advisory Board; Eli Lilly and Company Advisory Board (relationship ended), Research Support; Epitomee Medical Ltd Research Support; Novo Nordisk Research Support; WW International Inc. Research Support
  • Niel Floch, MD: Ethicon Social Media Consultant; Novo Nordisk Social Media Advisory Board
  • Claudia Fox, MD, MPH, FAAP, DABOM: Novo Nordisk Contracted Research; Eli Lilly and Company Contracted Research
  • Maria Daniela Hurtado Andrade, MD, PhD, DABOM: Eli Lilly Research Support; Novo Nordisk Advisory Board, Research Support; Phenomix Sciences Research Support
  • Ania Jastreboff, MD, PhD: Amgen Multi-center Trials, Scientific Advisory Board; Boehringer Ingelheim Multi-center Trials, Scientific Advisory Board; Eli Lilly Multi-center Trials, Scientific Advisory Board; Novo Nordisk Multi-center Trials, Scientific Advisory Board; Rhythm Pharmaceuticals Multi-center Trials; AstraZeneca Scientific Advisory Board; Biohaven Scientific Advisory Board; Intellihealth Scientific Advisory Board; Metsera Scientific Advisory Board; Pfizer Scientific Advisory Board; Regeneron Scientific Advisory Board; Scholar Rock Scientific Advisory Board; Sructure Therapeutics Scientific Advisory Board; Syntis Bio Scientific Advisory Board; Terns Pharmaceuticals Scientific Advisory Board; WeightWatchers Scientific Advisory Board; Zealand Pharmaceuticals Scientific Advisory Board
  • Judith Korner, MD, DABOM: Found Health Medical Advisory Board; Gila Therapeutics Scientific Advisory Board; Morphic Medical Scientific Advisory Board
  • Sonal Kumar, MD, MPH: Cymbay Therapeutics Advisory Board, Research Support; Gilead Sciences Research Support, Speaker; Intercept Pharmaceuticals Consultant, Research Support, Speaker; Ipsen Biopharmaceuticals Research Support, Speaker; Madrigal Pharmaceuticals Research Support; Novo Nordisk Research Support, Consultant
  • Anuradha Lala-Trindade, MD: Astra Zeneca National PI, Realize K Study; Boehringer Ingelheim Advisory Board; Merck National PI, Victor Study, Advisory Board; Novartis Speaker; Tenax Trial Steering Committee; Novo Nordisk Consultant and Steering Committee
  • Michael Rosenbaum, MD: Eli Lilly Researcher
  • Kartik Sampath, MD, DABOM: ConMed Inc. Consultant; Lumendi Inc. Consultant
  • Alpana Shukla, MD, MRCP (UK), FTOS: Eli Lilly and Company Research Funding; Novo Nordisk Research Funding
  • Beverly Tchang, MD, DABOM: Novo Nordisk Advisor; Eli Lilly Advisor; Skye Bioscience Advisor; Roman Health Ventures Advisor

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclaimer

All information in this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site. No single reference or service can take the place of medical training, education, and experience. This website does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a healthcare provider.

Technical Requirements

This activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all audio activities, you must have a sound card and speakers. You must have JavaScript and session cookies enabled on your computer to view graphic images and references that appear in separate "pop-up" windows. Adobe Acrobat Reader may be required for certain activities. Access to Vimeo streaming is required for this activity. 

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.